NCT03063008 is a NA clinical trial of PEEK in Vertebral Fusion, sponsored by Mohammad ARAB MOTLAGH.

Who is sponsoring NCT03063008?

NCT03063008 is sponsored by Mohammad ARAB MOTLAGH.

What drugs are being tested in NCT03063008?

Interventions in NCT03063008: PEEK, TiPEEK.

What condition does NCT03063008 study?

NCT03063008 studies Vertebral Fusion.

Is NCT03063008 still recruiting?

NCT03063008 is currently completed. Last updated 24 February 2017.

Last reviewed 2017-02-24 · How we verify

NCT03063008

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transforaminal Lumbar Interbody Fusion in PEEK Oblique Cages With and Without Titanium Coating

Completed NA Last updated 24 February 2017

What this trial tests

NA trial testing PEEK in Vertebral Fusion in 40 participants. Completed in 1 December 2013.

Timeline

16 January 2012

Primary endpoint
1 September 2013

1 December 2013

Quick facts

Lead sponsor	Mohammad ARAB MOTLAGH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	16 January 2012
Primary completion	1 September 2013
Estimated completion	1 December 2013

Drugs / interventions tested

PEEK
TiPEEK

Conditions studied

Vertebral Fusion — all drugs for Vertebral Fusion →

Sponsor

Mohammad ARAB MOTLAGH

Who can join

18 and older, any sex, with Vertebral Fusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical outcome with regard to oswestry disability index and lumbar fusion rate after implantation of titanium coated PEEK cage and common PEEK cage

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Editorial on "Transforaminal lumbar interbody fusion using polyetheretherketone oblique cages with and without a titanium coating: a randomised clinical pilot study".
Høy K, Li H. · · 2018 · cited 4× · PMID 30069546 · DOI 10.21037/jss.2018.06.09

Verify or expand the search:

Other trials of PEEK

Trials testing the same drug.

NCT06846632 — Graftless Technique in Open Maxillary Sinus Lifting Using PEEK Versus Ti -Meshwork · NA · completed
NCT05955222 — Clinical Performance of CAD/CAM Splint Materials · NA · completed
NCT03462862 — Evaluation of Candida Albicans Growth on BreFlex Versus PEEK Denture Base in Maxillary Bounded Partial Denture · NA · unknown
NCT03491306 — Evaluation of Microbial Growth on Bre-Flex Versus PEEK Denture Base in Bilateral Maxillary Bounded Partial Denture · NA · unknown

Other Mohammad ARAB MOTLAGH trials

Trials by the same sponsor.

NCT03859609 — Comparison of GAP-score With Schwab-score · completed
NCT03521661 — Efficacy of Kyphoplasty With a New Intervertebral Expander · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03063008 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mohammad ARAB MOTLAGH
Last refreshed: 24 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03063008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing